Liu, Yang <br/><br/>
A novel water-soluble benzothiazole derivative BD926 inhibits human activated T cell proliferation by down-regulating the STAT5 activation.  [electronic resource] 

 -  European journal of pharmacology  Aug 2015 
 - 36-43 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-0712 
<br/><br/><label>Standard No.: </label>10.1016/j.ejphar.2015.04.033  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Benzimidazoles--chemistry<br/>Benzothiazoles--chemistry<br/>Cell Proliferation--drug effects<br/>Cells, Cultured<br/>Cyclin D3--metabolism<br/>Cyclin-Dependent Kinase 6--metabolism<br/>Cytokines--metabolism<br/>Dermatitis, Allergic Contact--immunology<br/>Dinitrofluorobenzene<br/>Disease Models, Animal<br/>Dose-Response Relationship, Drug<br/>Down-Regulation<br/>Female<br/>G1 Phase Cell Cycle Checkpoints--drug effects<br/>Humans<br/>Immunosuppressive Agents--chemistry<br/>Indazoles--chemistry<br/>Lymphocyte Activation--drug effects<br/>Mice, Inbred BALB C<br/>Phosphorylation<br/>STAT5 Transcription Factor--metabolism<br/>Signal Transduction--drug effects<br/>Solubility<br/>T-Lymphocytes--drug effects<br/>Water--chemistry